Bone marrow characterization in COPD: a multi-level network analysis

dc.contributor.authorToledo Pons, Nuria
dc.contributor.authorNoell, Guillaume
dc.contributor.authorJahn, Andreas
dc.contributor.authorIglesias, Amanda
dc.contributor.authorDuran, Maria Antonia
dc.contributor.authorIglesias, Julio
dc.contributor.authorRios, Angel
dc.contributor.authorScrimini, Sergio
dc.contributor.authorFaner, Rosa
dc.contributor.authorGigirey, Orlando
dc.contributor.authorAgustí García-Navarro, Àlvar
dc.contributor.authorCosío, Borja G.
dc.date.accessioned2019-05-08T10:06:37Z
dc.date.available2019-05-08T10:06:37Z
dc.date.issued2018-06-15
dc.date.updated2019-05-08T10:06:37Z
dc.description.abstractBACKGROUND: Bone marrow (BM) produces hematopoietic and progenitor cells that contribute to distant organ inflammation and repair. Chronic obstructive pulmonary disease (COPD) is characterized by defective lung repair. Yet, BM composition has not been previously characterized in COPD patients. METHODS: In this prospective and controlled study, BM was obtained by sternum fine-needle aspiration in 35 COPD patients and 25 healthy controls (10 smokers and 15 never-smokers). BM cell count and immunophenotype were determined by microscopy and flow cytometry, respectively. Circulating inflammatory (C-reactive protein, IL-6, IL-8) and repair markers (HGF, IGF, TGF-β, VEGF) were quantified by ELISA. Results were integrated by multi-level network correlation analysis. RESULTS: We found that: (1) there were no major significant pair wise differences between COPD patients and controls in the BM structural characteristics; (2) multi-level network analysis including patients and controls identifies a relation between immunity, repair and lung function not previously described, that remains in the COPD network but is absent in controls; and (3) this novel network identifies eosinophils as a potential mediator relating immunity and repair, particularly in patients with emphysema. CONCLUSIONS: Overall, these results suggest that BM is activated in COPD with impaired repair capacity in patients with more emphysema and/or higher circulating eosinophils.
dc.format.extent10 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec686819
dc.identifier.issn1465-993X
dc.identifier.pmid29903047
dc.identifier.urihttps://hdl.handle.net/2445/132830
dc.language.isoeng
dc.publisherBioMed Central
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1186/s12931-018-0824-x
dc.relation.ispartofRespiratory Research, 2018, vol. 19, num. 1, p. 118-127
dc.relation.urihttps://doi.org/10.1186/s12931-018-0824-x
dc.rightscc-by (c) Toledo Pons, Nuria et al., 2018
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es
dc.sourceArticles publicats en revistes (Medicina)
dc.subject.classificationMalalties pulmonars obstructives cròniques
dc.subject.classificationMedul·la òssia
dc.subject.classificationAssaigs clínics
dc.subject.otherChronic obstructive pulmonary diseases
dc.subject.otherBone marrow
dc.subject.otherClinical trials
dc.titleBone marrow characterization in COPD: a multi-level network analysis
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
686819.pdf
Mida:
2.43 MB
Format:
Adobe Portable Document Format